Wilson John's most recent trade in Rollins, Inc. was a trade of 19,000 Common Stock done . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 19,000 | 609,107 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 632,067 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 628,107 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 628,767 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 629,427 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 630,087 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 630,747 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 660 | 631,407 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 58.04 per share. | 24 Jul 2025 | 30,000 | 632,727 (0%) | 0% | 58.0 | 1,741,200 | Common Stock |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 56.77 per share. | 29 May 2025 | 40,000 | 662,727 (0%) | 0% | 56.8 | 2,270,800 | Common Stock |
| RPC Inc | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 9,882 | 27,088 (0%) | 0% | - | Common Stock, $.10 Par Value | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 5,801 | 16,909 (0%) | 0% | - | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 09 Mar 2025 | 9,872 | 232,474 | - | 2.4 | 23,594 | Class A Common Stock |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 11,750 | 672,257 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.33 per share. | 20 Feb 2025 | 1,452 | 670,805 (0%) | 0% | 51.3 | 74,531 | Common Stock |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 89,000 | 89,000 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 44,000 | 242,346 | - | 0 | Class A Common Stock | |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.01 per share. | 18 Feb 2025 | 922 | 660,507 (0%) | 0% | 50.0 | 46,109 | Common Stock |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 11 Feb 2025 | 7,075 | 198,346 | - | 2.7 | 18,961 | Class A Common Stock |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.10 per share. | 06 Feb 2025 | 4,505 | 205,421 | - | 3.1 | 13,966 | Class A Common Stock |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.32 per share. | 28 Jan 2025 | 5,368 | 661,429 (0%) | 0% | 49.3 | 264,750 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 27 Jan 2025 | 8,372 | 666,797 (0%) | 0% | 49.5 | 414,414 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.46 per share. | 22 Jan 2025 | 3,299 | 675,169 (0%) | 0% | 48.5 | 159,870 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 48.77 per share. | 13 Dec 2024 | 10,252 | 678,468 (0%) | 0% | 48.8 | 499,990 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 16,500 | 668,216 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 720 | 684,716 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 720 | 685,436 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,250 | 14,100 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 4,348 | 11,108 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.98 per share. | 11 Mar 2024 | 9,569 | 188,738 | - | 1.0 | 9,387 | Class A Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 44.29 per share. | 06 Mar 2024 | 780 | 686,156 (0%) | 0% | 44.3 | 34,546 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 44.29 per share. | 06 Mar 2024 | 414 | 686,936 (0%) | 0% | 44.3 | 18,336 | Common Stock |
| Rollins | Wilson F. John | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 9,750 | 687,350 (0%) | 0% | 0 | Common Stock | |
| Rollins | F. John Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.05 per share. | 16 Feb 2024 | 924 | 677,600 (0%) | 0% | 41.0 | 37,930 | Common Stock |
| Rapid Micro Biosystems Inc (Class A) | Wilson John | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.96 per share. | 12 Feb 2024 | 5,809 | 198,307 | - | 1.0 | 5,577 | Class A Common Stock |
| Rapid Micro Biosystems Inc (Class A) | Wilson John | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 39,000 | 204,116 | - | 0 | Class A Common Stock | |
| Rollins | F. John Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.25 per share. | 26 Jan 2024 | 5,380 | 678,524 (0%) | 0% | 43.3 | 232,685 | Common Stock |
| Rollins | F. Wilson John | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.23 per share. | 26 Jan 2024 | 4,722 | 687,839 (0%) | 0% | 43.2 | 204,132 | Common Stock |
| Rollins | Wilson John F. | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.23 per share. | 26 Jan 2024 | 3,935 | 683,904 (0%) | 0% | 43.2 | 170,110 | Common Stock |
| Rollins | Wilson John F. | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.22 per share. | 23 Jan 2024 | 4,384 | 692,561 (0%) | 0% | 44.2 | 193,860 | Common Stock |
| Rollins | F. Wilson John | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.08 per share. | 22 Jan 2024 | 3,211 | 696,945 (0%) | 0% | 44.1 | 141,541 | Common Stock |
| Tigo Energy Inc | John Andrew Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 16,304 | 16,304 | - | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2023 | 2,415 | 738,537 (0%) | 0% | 0 | Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Jul 2023 | 3,040 | 740,952 (0%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Encore Wire Corp | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,250 | 12,850 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 28 Apr 2023 | 40,499 | 743,992 (0%) | 0% | 42.5 | 1,719,183 | Common Stock |
| RPC Inc | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 6,766 | 10,184 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 3,631 | 6,760 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 210,900 | 210,900 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 100,900 | 158,377 | - | 0 | Class A Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 8,250 | 784,491 (0%) | 0% | 0 | Common Stock | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 13 Feb 2023 | 7,075 | 57,477 | - | 1.3 | 9,198 | Class A Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.68 per share. | 30 Jan 2023 | 5,412 | 776,241 (0%) | 0% | 35.7 | 193,100 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 26 Jan 2023 | 5,412 | 786,163 (0%) | 0% | 36.1 | 195,590 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 26 Jan 2023 | 4,510 | 781,653 (0%) | 0% | 36.1 | 162,991 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.32 per share. | 23 Jan 2023 | 5,559 | 791,575 (0%) | 0% | 36.3 | 201,903 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.15 per share. | 23 Jan 2023 | 4,063 | 797,134 (0%) | 0% | 36.1 | 146,877 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.15 per share. | 23 Jan 2023 | 3,383 | 801,197 (0%) | 0% | 36.1 | 122,295 | Common Stock |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 39.54 per share. | 26 Oct 2022 | 32,000 | 804,580 (0%) | 0% | 39.5 | 1,265,280 | Common Stock |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Encore Wire Corp | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,250 | 11,600 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| RPC Inc | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 2,418 | 3,418 (0%) | 0% | 0 | Common Stock, $.10 Value | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 2,129 | 3,129 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 122,500 | 122,500 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc (Class A) | John Wilson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 61,250 | 61,250 | - | 0 | Class A Common Stock | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.96 per share. | 28 Jan 2022 | 5,412 | 836,580 (0%) | 0% | 30.0 | 162,144 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 29.70 per share. | 26 Jan 2022 | 50,000 | 848,080 (0%) | 0% | 29.7 | 1,485,000 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.70 per share. | 26 Jan 2022 | 6,088 | 841,992 (0%) | 0% | 29.7 | 180,814 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.90 per share. | 24 Jan 2022 | 12,434 | 798,080 (0%) | 0% | 31.9 | 396,645 | Rollins, Inc. Common Stock $1 Par Value |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 12,658 | 7,812,008 (16%) | 0% | 0 | Common Stock | |
| Kalaris Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Encore Wire Corp | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,250 | 10,350 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Marker Therapeutics Inc | John Wilson | Director | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 1,714,285 | 7,799,350 (16%) | 3% | 1.8 | 2,999,999 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 09 Mar 2021 | 52,440 | 5,510,514 | - | 31.3 | 1,641,157 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.70 per share. | 09 Mar 2021 | 30,506 | 5,480,008 | - | 31.7 | 966,921 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 09 Mar 2021 | 28,402 | 5,451,605 | - | 30.9 | 878,449 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.59 per share. | 09 Mar 2021 | 25,256 | 5,426,349 | - | 31.6 | 797,921 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 09 Mar 2021 | 17,480 | 3,197,475 | - | 31.3 | 547,052 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.87 per share. | 09 Mar 2021 | 10,188 | 5,415,261 | - | 30.9 | 314,535 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.70 per share. | 09 Mar 2021 | 10,169 | 3,187,306 | - | 31.7 | 322,318 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 09 Mar 2021 | 9,467 | 3,177,838 | - | 30.9 | 292,807 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.60 per share. | 09 Mar 2021 | 8,418 | 3,169,420 | - | 31.6 | 265,974 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.87 per share. | 09 Mar 2021 | 3,397 | 3,165,723 | - | 30.9 | 104,876 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 09 Mar 2021 | 2,308 | 5,412,953 | - | 31.6 | 72,997 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 32.31 per share. | 09 Mar 2021 | 900 | 5,425,449 | - | 32.3 | 29,081 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 09 Mar 2021 | 769 | 3,164,954 | - | 31.6 | 24,322 | Common Stock |
| Kalaris Therapeutics Inc | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 32.31 per share. | 09 Mar 2021 | 300 | 3,169,120 | - | 32.3 | 9,694 | Common Stock |
| Rollins | John F. Wilson | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 37.04 per share. | 26 Jan 2021 | 60,000 | 816,602 (0%) | 0% | 37.0 | 2,222,400 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.95 per share. | 26 Jan 2021 | 6,088 | 810,514 (0%) | 0% | 35.0 | 212,776 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.04 per share. | 23 Jan 2021 | 6,088 | 756,602 (0%) | 0% | 37.0 | 225,500 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.15 per share. | 23 Jan 2021 | 4,863 | 767,553 (0%) | 0% | 37.1 | 180,660 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.15 per share. | 23 Jan 2021 | 4,863 | 762,690 (0%) | 0% | 37.1 | 180,660 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.02 per share. | 22 Jan 2021 | 3,335 | 772,416 (0%) | 0% | 37.0 | 123,462 | Rollins, Inc. Common Stock $1 Par Value |